Plasmalogen content and distribution in the sarcolemma of cultured neonatal rat myocytes  by Post, J.A. et al.
Volume 240, number 1,2, 78-82 FEB 06506 November 1988 
Plasmalogen content and distribution in the sarcolemma of cultured 
neonatal rat myocytes 
J.A. Post, A.J. Verkleij *, B. Roelofsen+ and J.A.F. Op de Kamp+ 
Institute of Molecular Biology and Medical Biotechnology. *Department of Molecular Cell Biology and +Centre for 
Biomembranes and Lipid Enzymology. State University Utrecht, Padualaan 8.3584 CH Utrecht, The NetherIan& 
Received 30 September 1988 
Phospholipids are believed to play an important role in pathology and physiology of the myocardium. Because of the 
distinct physico-chemical properties of plasmalogens we studied the plasmalogen content and distribution in the sarco- 
lemma of cultured rat myocytes. Treatment with phospholipase 4 degraded all glycerophospholipids in the outer mono- 
layer. The hydrolysis products were analyzed for plasmalogen content. It is shown that the inner sarcolemmal leaflet 
is highly enriched in phosphatidylcholine and ethanolamine plasmalogen. This distribution of the plasmalogens might 
affect bilayer stability and thereby be involved in the destruction of the sarcolemma upon &hernia and reperfusion. 
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1. INTRODUCTION 
Phospholipids play an important role in the 
physiology and pathology of the myocardium. 
They are believed to be involved in the destruction 
of the sarcolemma during the calcium paradox [l] 
and ischemia reperfusion [2-41, as well as in 
excitation-contraction coupling in the myocardium 
[5,6]. Based on our morphological observations 
[3,4] we proposed that the physico-chemical 
characteristics of the sarcolemmal phospholipids 
play a key role in the destabilization and destruc- 
tion of the sarcolemma during reperfusion after 
prolonged ischemia [7]. Since, in this hypothesis, 
the localization of. the phospholipids in the sar- 
colemma is considered to be of particular impor- 
tance, we recently established the phospholipid 
distribution over the two halves of the sarcolem- 
ma1 lipid bilayer [8]. This study showed a highly 
asymmetric distribution: negatively charged 
phospholipids were found to be exclusively present 
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in the inner monolayer, this leaflet also containing 
75% of the phosphatidylethanolamine (PE) and 
57% of the phosphatidylcholine (PC), sphingo- 
myelin being largely (93%) confined to the outer 
monolayer. 
The physico-chemical properties of a 
phospholipid are determined not only by its polar 
head group, but also by the hydrophobic part of 
the molecule [9]. Both the fatty acid composition 
as well as the nature of the bonds between the 
aliphatic chains and glycerol backbone should be 
considered in this respect. The phospholipids of 
many biological membranes can be subdivided into 
diacyl and ether glycerophospholipids. In the latter 
group, the aliphatic chain at the sn-1 position is 
linked to the glycerol moiety by an ether rather 
than an ester bond. In most biological prepara- 
tions, two types of ether phospholipids may occur 
[lo] : (i) the 1-( 1’ -alkenyl)-2-acylglycerophos- 
pholipids or plasmalogens, having a Z double 
bond in the I-alkenyl moiety next to the ether 
linkage; and (ii) the 1-alkyl-2-acylglycerophospho- 
lipids, which have a saturated bond at this 
position. 
Ether phospholipids are less polar than the ester 
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analogues because of the absence of the .ester car- 
bony1 dipole(s), whereas they also differ in the 
steric arrangement of their respective 1’ -alkenyl- 
oxy, alkoxy and acyloxy groups [9]. Because of 
these differences in chemical structure, the sub- 
classes possess different physico-chemical proper- 
ties. This has been clearly shown in studying the 
phase behaviour of multilamellar dispersions of 
the three PE subclasses, which contained identical 
aliphatic moieties [ 111. It was shown that the phase 
transition temperature from the gel to the liquid 
crystalline state for l-( 1’ -alkenyl)-2-acylglycero- 
phosphatidylethanolamine (GPE) is about 5-6°C 
lower than that of the corresponding 1-alkyl-2- 
acyl-GPE and diacyl-GPE [ 11,121. 31P-NMR 
showed that the liquid to hexagonal II phase tran- 
sition temperature (Th) of plasmalogen PE (30°C) 
is dramatically lowered when compared to 1 -alkyl- 
2-acyl-GPE (53 “C) and diacyl-GPE (69” C) 
[11,13]. 
any intracellular material and leaving the sarcolemma ttached 
to the disk. Previous characterization [7] showed that such 
membranes are of high purity, although a small degree of 
mitochondrial contamination might occur. 
2.3. Phospholipase treatment 
Incubation of cells with phospholipase AZ was carried out 
with a mixture of bee venom phospholipase AZ (Sigma) and Na- 
ja naja phospholipase A2 (Sigma) at 37°C under gentle shaking 
for 75 min. 5 IU of both enzymes were added per disk in 4 ml 
buffer W in which CaCl2 was supplemented to 10 mM. At the 
end of incubations, disks were first extensively rinsed in buffer 
W and subsequently in this buffer containing 10 mM EDTA 
(Merck) to arrest phospholipase activity. Lysis of the cells was 
determined by measuring the release of lactate dehydrogenase 
1171. 
2.4. Lipid extraction and isolation of different phospholipid 
classes 
Extraction was accomplished by immersion of the disk with 
the attached cells or membranes in 4 ml isopropanol (Merck, 
analytical grade) for 60 min, which has been shown to extract 
all the lipids [8]. The phospholipids of gas-dissected membranes 
and of untreated cells were separated by two-dimensional thin- 
layer chromatography on HPLC plates (Merck). Phospholipids 
of phospholipase-treated cells were separated by two- 
dimensional thin-layer chromatography on TLC plates 
(Merck). Plates were first developed in chloroform/ 
methanol/water/ammonia (90: 54:5.5 :5.5, v/v) followed, 
after drying, by chloroform/methanol/water/acetic acid 
(90:40: 12:2, v/v) according to Broekhuyse [18]. Individual 
phospholipid spots were detected by mild iodine exposure and 
identified by using pure standards. After removal of iodine, the 
silica spots containing PC, PE, lyso-PC and lyso-PE were 
scraped off and phospholipids extracted as described by Arvid- 
son [19]. 
As it is obvious that the plasmalogens may con- 
tribute to the overall physico-chemical properties 
of the lipid bilayer of the sarcolemma, we deter- 
mined the content as well as the transbilayer 
distribution of these phospholipid species. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Culturing of cells was performed according to a modification 
of the method of Harary and Farley [14]. Neonatal rat (1-2 
days old) hearts were excised, minced and trypsinized as in [8]. 
Cells were plated on Falcon 3000 dishes for 2-3 h, during which 
fibroblasts adhere and myocytes remain freely suspended [15]. 
Finally, myocytes were plated on Primaria-treated culture disks 
(Falcon Plastics, Sumter, SC) and within 3 days a confluent 
monolayer of spontaneously beating cells was formed. Before 
use, on the third day, the disks with attached cells were exten- 
sively washed with buffer W (133 mM NaCl, 5 mM KCl, 1 mM 
MgCl2, 1 mM CaCl2, 10 mM Tris-HCl, 5 mM glucose; pH 
7.2). 
2.2. Isolation of the sarcolemma 
The gas dissection technique that we used has been described 
[8,16]. Briefly, the disk with attached cell monolayer is placed 
at the centre of a platform in a stainless-steel chamber. The 
chamber is closed and the platform that supports the disk is 
then elevated so that a valve, which extends into the chamber, 
makes firm contact with the centre of the disk. The construction 
of this valve is such that, upon rapid (< 1 s) opening of the inlet, 
a burst of highly compressed NZ produces a stream of high 
velocity parallel to the surface of the monolayer. This stream of 
Nz, which travels radially over the surface of the monolayer, 
tears open the upper surface of the cells, thereby blowing away 
2.5. Hydrolysis of bovine brain PE and pig brain PC to LPE 
and LPC 
Bovine brain PE (Sigma) or isolated pig brain PC were 
dissolved in ether/methanol (98: 2, v/v). Phospholipase A2 (bee 
venom and N. naja, 1: 1, U/U) was dissolved in 10 mM Tris- 
HCl (pH 7.4) containing 10 mM Ca” and added to the lipids. 
The reaction was performed by continuous vigorous stirring at 
room temperature. At the end of incubation, the mixture was 
centrifuged briefly to achieve good phase separation, the ether 
phase collected and the aqueous phase washed twice with ether. 
The reaction was monitored by using one-dimensional TLC on 
HPLC plates using the above acidic solvent system. 
2.6. Determination of plasmalogen content 
Lipid extracts were dried under a stream of N2, dissolved in 
1OOpl chloroform/methanol (1:2, v/v) and applied to an 
HPLC plate. In order to cleave the acid-labile 1 ‘-alkenyl ether 
bond of the plasmalogens, the HPLC plates were placed in the 
fumes of concentrated HCl [20] for 11 min. After drying, plates 
were developed using the above basic solvent system. The 
various products were visualised by iodine vapour and 
phosphorus reagent, scraped off and analyzed for phosphorus 
content [21] after destruction with 70% perchloric acid (30 min, 
180°C). It should be noted that the products of acid hydrolysis 
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of the I’-alkenyl ether bond in lyso-PC and lyso-PE, i.e. 
glycero-3-phosphocholine and -ethanolamine, remain at the 
origin of the TLC plate and do not react with the phosphorus 
reagent. 
3. RESULTS 
Determination of the plasmalogen content of 
PC and PE in whole cells and of isolated sarcolem- 
ma was carried out directly on total lipid extracts 
as described in section 2. In order to assess the 
distribution of PC and PE plasmalogens over the 
two monolayers of the sarcolemma, the following 
procedure was used: cells were treated with ex- 
ogenous phospholipase A2 in order to degrade all 
glycerophospholipids present in the outer 
monolayer of the sarcolemma. This can be 
achieved without cell lysis [8]. Lipids were ex- 
tracted from the phospholipase-treated samples 
and degraded phospholipids isolated and analyzed 
with respect to plasmalogen content. 
Table 1 shows the plasmalogen content of PC 
and PE isolated from cultured neonatal cells as 
well as gas-dissected membranes. The plasmalogen 
content of PE is markedly higher than that of PC. 
Furthermore, the plasmalogen content of either 
phospholipid in whole cells is slightly higher than 
that in the gas-dissected membranes. 
Treatment of cells with phospholipase A2 did 
not cause any significant lysis of myocardial cells, 
as assessed from the absence of any significant 
release of lactate dehydrogenase by cells during in- 
cubation. Incubation with phospholipase AZ 
resulted in hydrolysis of about 10% of total 
cellular PE and 19% of total cellular PC. These 
degraded fractions of PE (10%) and PC (19%) ac- 
count for the hydrolysis of all PE and PC present 
in the outer monolayer of the sarcolemma [8]. The 
plasmalogen content of each of these two 
lysophospholipids was significantly lower than 
that of the corresponding native phospholipids in 
the gas-dissected membranes (table 1). 
In order to ascertain that the determination of 
the plasmalogen content of lysophospholipids can 
indeed be carried out by using the same technique 
as is normally used in the case of intact 
phospholipids, bovine brain PE and pig brain PC 
were completely hydrolysed by phospholipase AZ. 
Thereafter, the above procedure was applied to 
determine the plasmalogen content of both the 
original phospholipids and the two lysophos- 
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Table 1 
Plasmalogen content of phospholipids of myocardial cells, their 
isolated sarcolemma, and of purified phospholipids and their 
completely hydrolyzed lysophospholipids 
% plasmalogen 
Cell PE 43.3 f 5.3 (8) 
Cell PC 18.8 f 2.7 (6) 
Gas dissected membrane PE 39.6 + 2.5 (7) 
Gas dissected membrane PC 15.6 + 1.4 (7) 
LPE 24.2 k 2.4 (8) p < 0.001 
LPC II.3 + 0.8 (4) p < 0.005 
Bovine brain PE 61.8 + 1.7 (3) 
LPE (derived from B.b.PE) 59.3 + 0.7 (3) 
Pig brain PC 6.2 + I.3 (3) 
LPC (derived from P.b.PC) 8.6 + 2.7 (3) 
Means + s (n); p: values of unpaired, two-tailed t-test compared 
to values of gas-dissected membranes 
pholipids derived from them. The plasmalogen 
content of lyso-PE, derived by complete hydrolysis 
of bovine brain PE, is essentially identical to that 
of the original PE (table 1). The same is observed 
for PC. 
4. DISCUSSION 
The unsaturated ether bond found in 
plasmalogens is cleaved by HCl vapour [20], 
resulting in a long-chain aldehyde and a 2-acyl-sn- 
glycero-3-phospholipid, which can be easily 
separated from other phospholipids. Using pig 
brain PC and bovine brain PE, as well as the cor- 
responding lyso derivatives that had been derived 
from them by phospholipase A2 treatment, it could 
be demonstrated that cleavage of the vinyl ether 
linkage in a I-alkenyl lyso derivative is as effective 
as in the case of the original 1-alkenyl-2-acyl- 
glycerophospholipids. This proves that the plas- 
malogen content of lysophospholipids, obtained 
after phospholipase AZ treatment of intact cells, 
can be determined by using exposure to HCl 
vapour and subsequent one-dimensional TLC and 
phosphorus analysis. Furthermore, it appeared 
that incubation of bovine brain PE and pig brain 
PC with phospholipase A2 from bee venom and N. 
naj, venom resulted in the complete hydrolysis of 
these phospholipids. This is in agreement with the 
observation that phospholipase A2 from N. naj~, 
unlike most other phospholipases [22], shows high 
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activity toward all three subclasses of PC [23] and 
may therefore be used for deacylation of the three 
subclasses [22]. We therefore used this enzyme, in 
combination with bee venom phospholipase A2, to 
treat cells and the results indeed indicate complete 
hydrolysis of all glycerophospholipids in the outer 
monolayer of the sarcolemma. 
The data presented in table 1 can be used to 
calculate the distribution of plasmalogens over the 
two monolayers of the sarcolemma. We have 
previously shown that 43% of the total sarcolem- 
ma1 PC is present in the outer monolayer [B]. It 
now appears that 11.3% of this PC fraction, deter- 
mined as lyso-PC, is present as plasmalogen (table 
1). This implies that (43 x 0.0113 =) 4.9% of the 
sarcolemmal PC is present in the outer monolayer 
in the form of plasmalogen and that consequently 
(43 - 4.9 =) 38.1% is present as diacyl- and 
alkylacyl-GPC. The inner monolayer of the sar- 
colemma, containing 57% of the sarcolemmal PC, 
then contains (15.6 - 4.9 =) 10.7% of the sar- 
colemmal PC as plasmalogen and 46.3% as diacyl- 
and alkylacyl-GPC. 
A similar calculation shows that of the 25% of 
the sarcolemmal PE we have shown to be present 
in the outer monolayer [8] 24.2% consists of the 
plasmalogen form (table l), representing 6.1% of 
total sarcolemmal PE. The inner monolayer, 
which contains 75% of the sarcolemmal PE, then 
contains 33.5% of the sarcolemmal PE in the 
plasmalogen form. 
These results, summarized in fig. 1, clearly show 
that the plasmalogen forms of PC and PE are both 
asymmetrically distributed in the sarcolemma. Not 
less than 84% of plasmalogen PE is present in the 
inner monolayer, whereas this layer accommodates 
74% of total sarcolemmal PE. This implies that 
the inner monolayer is highly enriched in 
plasmalogen PE, compared to the outer 
monolayer. Plasmalogen PE accounts for 44.7% 
of PE in the inner monolayer and for only 24.2% 
of that in the outer sarcolemmal eaflet. Similar 
calculations show that, of the total PC in the inner 
monolayer, 18.8% is plasmalogen, this value being 
11.3% for the outer monolayer pool. 
It should be noted that the sarcolemmal prepara- 
tion we used has some mitochondrial contamina- 
tion (81 which, by itself and in the case where 
mitochondria might have a very high plasmalogen 
content, could already partly explain the above 
Fig. 1. Phospholipid composition and transbilayer distribution 
in the sarcolemma of cultured rat heart cells. PC and PE 
plasmalogens are indicated by the black portion of the bars 
(TPL, total phospholipids; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PUPI, phosphatidylserine/- 
inositol; Sph, sphingomyelin). 
results. Gross [24], however, showed that cardiac 
mitochondria contain little plasmalogen PE com- 
pared to sarcolemma. The plasmalogen content we 
determined for the PC and PE from the gas- 
dissected membranes is lower than that reported 
for canine sarcolemma [25]. However, it has been 
shown that the plasmalogen content may vary be- 
tween myocardial tissue of different species [26]. 
The transbilayer distribution of plasmalogens 
reported here is at variance with that reported for 
the red cell membrane. By using trinitro- 
benzenesulfonic acid no significant differences in 
the molecular species composition of PE localized 
in the inner and outer monolayer were observed 
[27]. It was observed recently that the relative 
amounts of plasmalogen PE in both outer and in- 
ner monolayer pools of PE in the human red cell 
membrane are essentially identical (Middelkoop, 
E., personal communication). 
One interesting aspect of the relatively high 
plasmalogen content of the inner monolayer of the 
sarcolemma might be a role in the control of 
cellular calcium. High plasmalogen contents seem 
to be a characteristic of electrically active tissue 
which suggests ome involvement in the control of 
excitation. It has been shown that choline 
plasmalogens appear to differ in their molecular 
dipole as compared with diacyl-GPC [9,28] and ex- 
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hibit a decreased surface potential vs diacyl-GPC 
[28]. Seelig et al. [29] have demonstrated that the 
binding/adsorption of metal ions modifies the 
membrane surface potential. Conversely, metal 
ions may be attracted to, or released from a mem- 
brane surface by changes in its surface potential. It 
might very well be that this mechanism, together 
with specific properties of the plasmalogens, is in- 
volved in excitation/contraction coupling, in 
which sarcolemmal bound calcium is believed to 
play a central role [5,6]. 
Another important aspect of the relative high 
plasmalogen content, especially of PE plasma- 
logen, of the sarcolemmal inner leaflet is the rather 
low lamellar to hexagonal II transition 
temperature (Th) of the PE plasmalogen as com- 
pared with diacyl- and alkylacyl-GPE [ 11,131. We 
recently proposed [7] that an increase in in- 
tracellular Ca2+ during reperfusion after prolong- 
ed ischemia, causes a lateral phase separation of 
the phospholipids in the inner monolayer of the 
sarcolemma. Due to this separation, the lipid 
bilayer destabilizes because of the ‘no longer con- 
trolled’ non-bilayer behaviour of PE. The present 
data show that plasmalogen PE accounts for 45% 
of the PE present in the inner monolayer of the 
sarcolemma, having a relatively low Th. This im- 
plies that the inner monolayer of the sarcolemma 
is in a rather unstable bilayer configuration, which 
might be easily disturbed by the occurrence of 
lateral phase separations, for instance those caused 
by an increase of cytosolic Ca2+ upon prolonged 
ischemia and reperfusion. 
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